Beactica is a specialist drug discovery company utilising its proprietary methodologies to evaluate the interaction of molecules in order to generate novel therapeutics. 

We believe in our ability to improve patients’ lives through our passion for science. With informed and creative minds we innovate novel small molecule modulators to become next-generation breakthrough therapies for life-threatening conditions.

Press releases


Upcoming events

20–21 May 2019, Beactica presents and participates in partnering at BioEquity Europe 2019 in Barcelona, Spain.